|
You are here: Home: BCU 6|2002: Faculty Financial Interest
Faculty of this educational activity will discuss published and/or
investigational uses
of agents that are not indicated by the FDA. The Postgraduate Institute
for Medicine
and NL Communications, Inc. do not recommend the use of any agent
outside of the
labeled indications. Please refer to the official prescribing information
for each product
for discussion of approved indications, contraindications and warnings.
Faculty financial interests or affiliations
Joyce O'Shaughnessy, MD
Consultant: Roche Laboratories, Inc.
Speakers’ Bureau: Roche Laboratories, Inc.,
Aventis Pharmaceuticals, Ortho, Eli Lilly & Co.
Daniel Hayes, MD
Grants/Research Support: AstraZeneca Pharmaceuticals,
LP
Consultant: Genentech, Inc., AstraZeneca Phamaceuticals,
LP, Aventis Pharmaceuticals,
Bristol-Myers Squibb, Novartis, Wyeth Ayerst-Genetics Institute
Melody Cobleigh, MD
Grants/Research Support: Genentech, Inc., Agouron,
Amgen, Aventis Pharmaceuticals,
Bristol-Myers Squibb, Coley Pharmaceuticals, Genentech, Inc., Genta,
Inc., Immunicon,
Novartis, SmithKline Beecham
Speakers’ Bureau: Genentech, Inc.
John F Robertson, MD, FRCS
Grants/Research Support: AstraZeneca Pharmaceuticals,
LP
Consultant: AstraZeneca Pharmaceuticals, LP
|
|
